New "21st Century Cures" Legislation: Speed and Ease vs Science

JAMA. 2017 Feb 14;317(6):581-582. doi: 10.1001/jama.2016.20640.

Authors

Aaron S Kesselheim¹, Jerry Avorn¹

Affiliation

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 28056124
DOI: 10.1001/jama.2016.20640

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Budgets / legislation & jurisprudence
Drug Approval / legislation & jurisprudence*
Drug Industry / standards
Financing, Government / legislation & jurisprudence*
National Institutes of Health (U.S.) / economics
National Institutes of Health (U.S.) / legislation & jurisprudence*
Politics
Research Support as Topic / economics
Research Support as Topic / legislation & jurisprudence*
Science / legislation & jurisprudence*
United States
United States Food and Drug Administration / legislation & jurisprudence*
United States Food and Drug Administration / standards